Skip to main content
TipRanks
Go Ultimate75% OFF

Polaryx Therapeutics, Inc. (PLYX) Income Statement

24 Followers

Polaryx Therapeutics, Inc. Income Statement

Last quarter (Q3 2026), Polaryx Therapeutics, Inc.'s total revenue was $0.00. In Q3, Polaryx Therapeutics, Inc.'s net income was $-3.33M. See Polaryx Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23
$ 0.00$ 0.00$ 0.00
$ 0.00$ 0.00$ 0.00
$ 7.82M$ 4.35M$ 3.78M
Depreciation and Amortization$ 0.00$ 0.00$ 0.00
$ -8.98M$ -30.36M$ -3.78M
$ -7.82M$ -4.35M$ -3.78M
$ -1.16M$ -26.00M$ 2.00K
$ -8.98M$ -30.36M$ -3.78M
$ -8.98M$ -30.36M$ -3.78M
Per Share Metrics
Basic EPS$ -0.19$ -0.16$ -0.15
Diluted EPS$ -0.19$ -0.16$ -0.15
Weighted Average Shares Outstanding47.34M189.37M24.51M
Weighted Average Shares Outstanding (Diluted)47.34M189.37M24.51M

Currency in USD

Polaryx Therapeutics, Inc. Earnings and Revenue History

-36M-24M-12M00 %0.4 %0.8 %1.2 %EarningsProfit Margin202320242025RevenueEarningsProfit Margin